Viewing Study NCT01526434


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-31 @ 9:45 PM
Study NCT ID: NCT01526434
Status: COMPLETED
Last Update Posted: 2014-03-19
First Post: 2012-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol
Sponsor: UCB Pharma SA
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: RA0053
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View